Gregory Russotti - 02 Feb 2023 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Role
Chief Technology Officer
Signature
/s/ Michael Diem, Attorney-in-Fact
Issuer symbol
IPSC
Transactions as of
02 Feb 2023
Net transactions value
$0
Form type
4
Filing time
06 Feb 2023, 17:51:27 UTC
Previous filing
27 Jan 2022
Next filing
13 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IPSC Stock Option (right to buy) Award $0 +175,000 $0.000000 175,000 02 Feb 2023 Common Stock 175,000 $4.64 Direct F1
transaction IPSC Stock Option (right to buy) Award $0 +175,000 $0.000000 175,000 02 Feb 2023 Common Stock 175,000 $4.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on February 2, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.